• FirefoxInstall the new Firefox »
  •  Dow Up1.49% Nasdaq Up1.15%

    Ultragenyx Pharmaceutical Inc. (RARE)

    -NMS
    60.95 Up 4.39(7.76%) Mar 30, 4:00PM EDT
    |After Hours : 60.95 0.00 (0.00%) Mar 30, 4:53PM EDT
    Add to Portfolio
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Net Income (35,070) (16,334) (6,849)
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation1,857  313  34  
    Adjustments To Net Income3,558  1,193  537  
    Changes In Accounts Receivables -   -   -  
    Changes In Liabilities2,663  2,363  702  
    Changes In Inventories -   -   -  
    Changes In Other Operating Activities(4,208)(39)(249)
    Total Cash Flow From Operating Activities (31,200) (12,504) (5,825)
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(407)(1,091)(548)
    Investments(47,352) -   -  
    Other Cash flows from Investing Activities25  (100)(376)
    Total Cash Flows From Investing Activities (47,734) (1,191) (924)
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid -   -   -  
    Sale Purchase of Stock171  89,140  14,879  
    Net Borrowings -  100  2,450  
    Other Cash Flows from Financing Activities -   -   -  
    Total Cash Flows From Financing Activities 171   89,240   17,329  
    Effect Of Exchange Rate Changes -   -   -  
    Change In Cash and Cash Equivalents (78,763) 75,545   10,580  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.